Ribi Immunochem
Executive Summary
Recent completion of a $2.8 mil., 17,000 sq ft addition at the firm's Hamilton, Montana headquarters brings total operating space to 40,000 sq ft. The expansion "nearly triples the area for R&D acti-vities and more than doubles the area for production," Ribi said. The company's melanoma vaccine, which incorporates the antitumor agent Detox as an adjuvant, is currently in Phase II trials.